(Q36647141)

15 August 2017

1 reference

title

Effects of inhaled steroids on growth, bone metabolism, and adrenal function (English)

1 reference

15 August 2017

David B Allen

1

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

published in

Advances in pediatrics

1 reference

15 August 2017

volume

53

1 reference

15 August 2017

page(s)

101-110

1 reference

Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy,

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Potential adverse effects of the inhaled corticosteroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Systemic effect comparisons of six inhaled corticosteroid preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Sense and sensitivity: assessing inhaled corticosteroid effects on the hypothalamic-pituitary-adrenal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Acute adrenal crisis in asthmatics treated with high-dose fluticasone propionate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Budesonide: safety and efficacy aspects of its long-term use in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Long-term effect of budesonide on hypothalamic-pituitary-adrenal axis function in children with mild to moderate asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Safety of inhaled corticosteroids in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Long-term effects of budesonide or nedocromil in children with asthma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Systemic activity of inhaled steroids in 1- to 3-year-old children with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Growth and bone density in children with mild-moderate asthma: a cross-sectional study in children entering the Childhood Asthma Management Program (CAMP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Long-term safety of fluticasone propionate and nedocromil sodium on bone in children with asthma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

Children and the risk of fractures caused by oral corticosteroids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YAPD.2006.04.006

10.1016/J.YAPD.2006.04.006

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference